7-21861927-C-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001277115.2(DNAH11):āc.11277C>Gā(p.Ile3759Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000692 in 1,613,490 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001277115.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH11 | ENST00000409508.8 | c.11277C>G | p.Ile3759Met | missense_variant | 69/82 | 5 | NM_001277115.2 | ENSP00000475939.1 | ||
DNAH11 | ENST00000421290.1 | n.460C>G | non_coding_transcript_exon_variant | 4/4 | 4 | |||||
DNAH11 | ENST00000607413.5 | n.540C>G | non_coding_transcript_exon_variant | 4/4 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000631 AC: 96AN: 152062Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000310 AC: 77AN: 248658Hom.: 0 AF XY: 0.000267 AC XY: 36AN XY: 134898
GnomAD4 exome AF: 0.000698 AC: 1020AN: 1461428Hom.: 0 Cov.: 30 AF XY: 0.000664 AC XY: 483AN XY: 726996
GnomAD4 genome AF: 0.000631 AC: 96AN: 152062Hom.: 1 Cov.: 32 AF XY: 0.000713 AC XY: 53AN XY: 74288
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Primary ciliary dyskinesia 7 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 12, 2022 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jun 29, 2023 | BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at